Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Jul 2023 for Cyclacel Pharmaceuticals, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Christopher S. Henney: trading record in brief
Christopher S. Henney, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Prothena CORP Public Ltd Co and Bio Green Med Solution, Inc. We count 7 filings; the first trade dates from 15 June 2021 and the latest from 30 June 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 3 July 2023 with a share grant in Bio Green Med Solution, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christopher S. Henney
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
21,219 shares0Common StockSEC:0001104659-23-077651:0
15,822 shares0Common StockSEC:0001104659-22-071893:0
11,108 shares@ US$11.3326.1% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-21-013567:0
17,500 shares@ US$9.230.026% mcap12.5% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-21-024235:0
17,500 shares@ US$9.2333.4% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-21-024156:0
12,000 shares@ US$16.4340.5% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-21-012739:0
2,374 shares0Common StockSEC:0001104659-21-082599:0
7 of 7 declarations
